RFTH/LinkedIn
Sep 8, 2026, 15:21
ISTH 2026 Highlights, Expert Insights Into Thrombosis and Hemostasis – RFHT
RFHT (Revue Francophone d’Hémostase et Thrombose), shared a post on LinkedIn:
“The essentials of ISTH 2026 deciphered in interviews
- How can you go even further with emicizumab? Cedric Hermans, Liège, Belgium
- NETs in all their facets: formation, fate and elimination, chloé James, Bordeaux
- API CAT: what do we know about venous thromboembolic recurrences with apixaban? Isabelle Mahé, Colombes
- What clinical lessons can be learned from the 3year data from the CASSIOPEIA study on venous thromboembolism? Laurent Frenzel, New York, United States
- Von Willebrand disease: should the 2B variants be reclassified New York? Melanie Daniel, Lille
- Endothelial cells: a new role in the mechanisms of thrombosis? David Smadja, Paris
- Post MTEV patient caregiver communication session: a new tool to improve living better with one’s pathology? Francis Couturaud, Brest
- Can we still improve the prevention of thrombotic risk? Catherine Lemarie, Brest”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 23, 2026, 16:05Platelet Secretion Defects and Their Role in the Diagnosis of Bleeding Disorders
-
Oct 23, 2026, 16:00Hemophilia Alliance team in New Orleans at the ATHN Data Summit
-
Oct 23, 2026, 15:49Brian Sapp: Why Exact Calf Vein Naming Is Critical for DVT Diagnosis?
-
Oct 23, 2026, 15:33Smitirupa Mishra: A Systematic Approach to Bone Marrow Examination
-
Oct 23, 2026, 15:29José Antonio García Erce: Preoperative Anemia Emerges as a Modifiable Surgical Risk in New POWER Study
-
Oct 23, 2026, 15:13Reza Shojaei: Manufactured Red Blood Cells vs Blood Donation
-
Oct 23, 2026, 14:29Jean Jacques Kiladjian: International Scientific Exchange at IHCAMS in Tianjin
-
Oct 23, 2026, 14:11Aravind Palraj: The Prolonged aPTT Puzzle in SLE
-
Oct 23, 2026, 13:56Chokri Ben Lamine: The Evolving Treatment Landscape of Persistent and Chronic ITP